AVF

PROCEDURE3 trials

Sponsors

Humacyte, Inc., Haiyan Wang, Wroclaw Medical University

Conditions

Arteriovenous FistulaDialysis; ComplicationsEnd Stage Renal DiseaseEnd Stage Renal Disease (ESRD)Vascular Access Complication

Phase 3

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

Active, not recruitingNCT05908084

Humacyte, Inc.End Stage Renal Disease (ESRD)

Start: 2023-09-07End: 2028-06-01Updated: 2026-06-26

Unknown Phase

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

CompletedNCT06199609

Haiyan WangArteriovenous Fistula, End Stage Renal Disease

Start: 2022-09-01End: 2023-11-30Updated: 2024-01-10

Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.

RecruitingNCT06550479

Wroclaw Medical UniversityDialysis; Complications, Vascular Access Complication

Start: 2024-01-01End: 2030-07-31Target: 180Updated: 2024-08-13

Related Papers

New-onset atrial fibrillation following arteriovenous fistula increases adverse clinical events in dialysis patients with end-stage renal disease.

2024-04-125 citations